Cargando…
Mesenchymal stem cells abrogate experimental asthma by altering dendritic cell function
Mesenchymal stem cells (MSCs) have been investigated in the treatment of numerous autoimmune diseases. However, the immune properties of MSCs on the development of asthma have remained to be fully elucidated. Airway dendritic cells (DCs) have an important role in the pathogenesis of allergic asthma,...
Autores principales: | ZENG, SHAO-LIN, WANG, LI-HUI, LI, PING, WANG, WEI, YANG, JIONG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464445/ https://www.ncbi.nlm.nih.gov/pubmed/25936350 http://dx.doi.org/10.3892/mmr.2015.3706 |
Ejemplares similares
-
Dimethyl fumarate abrogates dust mite‐induced allergic asthma by altering dendritic cell function
por: Jaiswal, Anil K., et al.
Publicado: (2019) -
In vivo depletion of lung CD11c(+) dendritic cells during allergen challenge abrogates the characteristic features of asthma
por: van Rijt, Leonie S., et al.
Publicado: (2005) -
Placenta-Derived Mesenchymal Stem Cells Reduce the Interleukin-5 Level Experimentally in Children with Asthma
por: Lin, Sheng-Chieh, et al.
Publicado: (2019) -
Interferon-α Abrogates Tolerance Induction by Human Tolerogenic Dendritic Cells
por: Bacher, Nicole, et al.
Publicado: (2011) -
Administration of JTE013 abrogates experimental asthma by regulating proinflammatory cytokine production from bronchial epithelial cells
por: Terashita, Tomomi, et al.
Publicado: (2016)